C-B5LQJunevity
siRNA, gene network reset, machine learning
reprogrammingrna therapeutic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-B5LQ
C-B5LQC-B5LQsiRNA, gene network reset, machine learning
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Contact — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Contact us Email: [email protected] Newsletter: subscribe here ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT LINKEDIN All Rights Reserved © 2026 Junevity Inc.
Careers — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT WE CREATE BREAKTHROUGH THERAPIES FOR HUMAN LONGEVITY Junevity is looking for world-class people ready to tackle challenging problems in bioinformatics, drug discovery, therapeutic development, and company-building. On our 80th (and 120th) birthdays, we will remember our time at Junevity as our life’s work. This will be the work we are most proud of, w
Beyond Anti-Aging: The Skin Longevity Revolution Reshaping Beauty in 2025 - Beauty Ingredients & Formulation Asia Skip to content 繁 简 EN Facebook Linkedin Instagram Where Science Shapes the Future of Beauty ABOUT WHAT IS BIFA? WHY ATTEND TICKET & PRICING SCIENTIFIC ADVISORY BOARD 2026 EVENT CODE OF CONDUCT SPEAKERS SPEAKERS 2026 SPEAKERS 2025 BECOME OUR SPEAKER AGENDA AGENDA 2026 AGENDA 2025 SPONSORS SPONSORSHIP SPONSORSHIP OPPORTUNITIES MEDIA PRESS RELEASES MEDIA PARTNERS INDUSTRY CONTENT TRAVEL TRAVELLING TO HONG KONG FLIGHTS VISA APPLICATION CONTACT US ABOUT WHAT IS BIFA? WHY ATTEN … SES MEDIA PARTNERS INDUSTRY CONTENT TRAVEL TRAVELLING TO HONG KONG FLIGHTS VISA APPLICATION CONTACT US 10-11 NOV 2026 HONG KONG ASIAWORLD-EXPO ABOUT WHAT IS BIFA? WHY ATTEND TICKET & PRICING SCIENTIFIC ADVISORY BOARD 2026 EVENT CODE OF CONDUCT SPEAKERS SPEAKERS 2026 SPEAKERS 2025 BECOME OUR SPEAKER AGENDA AGENDA 2026 AGENDA 2025 SPONSORS SPONSORSHIP SPONSORSHIP OPPORTUNITIES MEDIA PRESS RELEASES MEDIA PARTNERS INDUSTRY CONTENT TRAVEL TRAVELLING TO HONG KONG FLIGHTS VISA … SES MEDIA PARTNERS INDUSTRY CONTENT TRAVEL TRAVELLING TO HONG KONG FLIGHTS VISA APPLICATION CONTACT US ABOUT WHAT IS BIFA? WHY ATTEND TICKET & PRICING SCIENTIFIC ADVISORY BOARD 2026 EVENT CODE OF CONDUCT SPEAKERS SPEAKERS 2026 SPEAKERS 2025 BECOME OUR SPEAKER AGENDA AGENDA 2026 AGENDA 2025 SPONSORS SPONSORSHIP SPONSORSHIP OPPORTUNITIES MEDIA PRESS RELEASES MEDIA PARTNERS INDUSTRY CONTENT TRAVEL TRAVELLING TO HONG KONG FLIGHTS VISA APPLICATION CONTACT US GET TICKETS Beyon
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio | FirstWord PHARMA You need to enable JavaScript to run this app. Loading...
Slice of Healthcare Thoughts Podcast Editions Awards Search SIGN IN SUBSCRIBE Where healthcare's leaders tell their stories. Join 20,000+ operators across health systems, payers, enterprises, and startups. Subscribe free Presented by Sage Growth Partners Trusted and enjoyed by leaders across healthcare United Healthcare • Mayo Clinic • Ascension • Lifepoint Health • Novant Health • Tampa General Hospital • NYU Langone Health • BlueCross Blue Shield of Arizona • Beth Israel Lahey Health • UCLA Health • Dubai Health Authority • Kaiser Permanente • Labcorp • National Kidney Foundation • BayC
John Hoekman - Google Scholar Loading... The system can't perform the operation now. Try again later. Citations per year Duplicate citations The following articles are merged in Scholar. Their combined citations are counted only for the first article. Merged citations This "Cited by" count includes citations to the following articles in Scholar. The ones marked * may be different from the article in the profile. Add co-authors Co-authors Follow New articles by this author New citations to this author New articles related to this author's research Email address for updates Done Sorry, s
Obesity Science & Innovation You need to enable JavaScript to run this app. This site is part of the Informa Connect Division of Informa PLC Informa PLC About Us Investor relations Talent This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. September 23-24, 2026 | Part of Biotech Week Boston Hynes Convention Center Boston, United States Home home 2026 Program expand_more Agenda Speakers Sponsors & Exhibitors Add
5 Biotech Companies Poised for 2026 Commercialization | ACS Recruiting & Associates, LLC posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to joi
AI in Healthcare Event | Bloomberg Events Event is at capacity and registration is now closed. Please email [email protected] to be added to the waitlist. Minds, Medicine & Machines: AI and the Future of Healthcare Tuesday May 12, 2026 6:00 – 8:00pm PT The Exploratorium Pier 15 (Embarcadero at Green Street) San Francisco, CA 94111 Join members of Bloomberg Women’s Buy-side Network and CFA Society SF, as we bring together leaders from Stanford Medicine, Andreesen Horovitz, Open AI and Junevity to discuss how AI is rewriting the rules of diagnostics, drug discovery and patient care a … Job Role Select One Accountant / Controller Administrative / Assistant Analyst Application Developer Application Owner Back Office Broker Business Development / Sales Business Manager Capital Markets Cash Manager Chief Compliance Officer Chief Data Officer Chief Diversity Officer Chief Executive Officer Chief Financial Officer Chief Information Officer Chief Investment Officer Chief of Staff Chief Operating Officer Chief Risk Officer Chief Sustainability Officer Chief Techno … he privacy policy and to learn more about products and services from Bloomberg. SUBMIT Sending... For questions, please email BWBN: California About the Bloomberg Women’s Buy-side Network The Bloomberg Women’s Buy-Side Network (BWBN) is dedicated to inclusivity, education and connectivity to help bring together women and allied industry leaders. This comes to life through mentoring, sponsorship, and networking in regional chapters across the globe. About CFA Soci
Taiwan - Biotech Companies - Careers Page About Directory Promoted Listings Purchase Data Drug Pipelines Data Licensing Weekly Update Newsletter Contact Taiwan - Biotech Companies - Career Pages Silgan Unicep Spokane, WA Contract Filling & Packaging Laboratorio Reig Jofre Barcelona, Spain Pharma manufacturing (antibiotics/injectable HeavyBio Shenzhen, China Antibodies, Antigens Solaris Biotech Cambridge, MA Specialized bioprocessing equipment for biotech, pharma, food + more. Benchtop / Pilot / Industrial Bioreactors, Fermenters, TFF. ACTA Laboratories , Website d … er, BC Cellular Products Corinth MedTech , Website down Sep 2023; Did not submit annual report in 2022 or 2023 Aerin Medical Mountain View, CA Nasal Obstruction Relief Device Galvani Bioelectronics Stevenage, UK Miniaturized, implantable devices Bacainn Therapeutics , Now part of Adiso Therapeutics 9 Meters Biopharma , Bankrupt Jul 2023; fka Innovate Biopharmaceuticals, Merged with RDD Pharma Apr 2020 Molecular Throughput , Rebranded as mti … sp;BioPact Austin, TX Carbon-nanotube based rebar Halsa Pharmaceuticals , Award in 2008, No additional info, presume defunct Navinta Ewing, NJ Generics Integromics , Bought by Perkin-Elmer 2017 Regenerative Sciences , Took on Regenexx product name Anterion Therapeutics , Bankrupt Feb 2012 RegeneraTEch , Renamed Regencor Medtronic Galway, Ireland Medical Devices Swedish Orphan Biovitrum Waltham, MA Biologics Allakos , Acqui … on Channel Innovations , Primitive website, no apparent employees. Got $1M SBIR grant in 2013 Cullinan Therapeutics Cambridge, MA In-Licensing & Developing Oncology Assets for Sale Lipid Knowledge , Website gone, reported as closed on Google, Jan 2024 Bar Harbor Biotech , Dissolved Jul 2015 Click Diagnostics , Renamed Visby Medical, Jun 2019 Piramal Mumbai, India CDMO ADMA Biologics Ramsey, NJ Biologics LFB Paris, France Plasma derive … sp;Curie Therapeutics , Renamed Mariana Oncology Evas Therapeutics , SBIR grant. No info Jun 2015. Google says closed Aug 2019 Acrivon Therapeutics Lund, Sweden Checkpoint Inhibitor Pyrotech Therapeutics Beijing, China Small Molecule Drugs, Gene Regulation Therapies-Innate Immunity & Pyroptosis Modulators Periblation Medic
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter | FirstWord PHARMA You need to enable JavaScript to run this app. Loading...
Skip to content How It Works Pricing Blog Events Partners Search orgs, people, news, resources... ⌘K Sign In Get Started → Search organizations, people, news, resources, and content... / How It Works Pricing Blog Events Partners Sign In Get Started → Loading organizations... The OS for early-stage founders from day zero to raise. Subscribe Product How It Works Pricing Partners Resources Blog Events Contact Company About Privacy Terms © 2026 Startup Intros, Inc. San Francisco, CA · Made for Founders Goldcrest Capital: Funding, Team & Investors | Startup Intros Home / Organizations / Goldcre … t Capital § Venture Capital · Dallas, TX, USA Goldcrest Capital venture capital fund that identifies and funds early-stage private technology companies across the United States. Active Venture Capital Website LinkedIn Subscribe Copy .md Share Updated: Apr 16, 2026 Suggest an Edit About News Financials Team Deep Dive FAQs Quick Facts Type Investment Firm Status Active Founded 2026 HQ Dallas, TX, USA Employees 1-10 IPO Status Private Focus B2B, Big Data, FinTech +3 Stage Early … ple investment vehicles and is currently raising a $125 million venture capital fund. This new vehicle, Goldcrest Capital IV, launched in October 2025 and follows previously closed funds such as Goldcrest Capital II from August 2018. Key personnel managing the firm's investment strategy and daily operations include Managing Director Daniel Friedland, Partner Adam Ross, and Vice President of Finance Veronique Chang. The venture capital organization was originally founded by Da … .html venturecapitaljournal.com/goldcrest-capital-raise-125-mln-venture-capital-fund Leadership Team 3 people Key people at Goldcrest Capital . AR Adam Ross N/A Evan Lowenstein Limited Partner Dan Friedland Managing Director Investment Activity Goldcrest Capital has more than 26 tracked investments across 18 companies. The latest tracked deal is $65.0M Series C in Sage in March 2026. Investments 26+ 18 companies Investments Made Date Company Round Lead Investor(s) Co-Investor … tz , Base Partners , Bond , CapitalG , Company Capital , E1 Ventures , Founders Fund , General Catalyst , Graypes GmbH , Highbury Group , SciFi VC , Henry Fertik , UpHonest Capital , Aaron Levie , Elon Musk , Fanny Surjana , Jean Sébastien Wallez , Liam Casey , Matt Mazzeo , Michael Moritz , Pratik Kapoor , Richard Cooperstein , Peter Thiel , Ala
Junevity Secures $20M for siRNA Cell Reprogramming Platform | cGxP.wire posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agr … ticularly strong interest in Treg-based therapies, boosted by this year’s Nobel Prize recognizing foundational Treg research. 🔹 𝟲. 𝗔𝗜 𝗕𝗲𝗰𝗼𝗺𝗲𝘀 𝘁𝗵𝗲 𝗕𝗮𝗰𝗸𝗯𝗼𝗻𝗲 𝗼𝗳 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 AI has moved from a buzzword to an essential infrastructure layer, powering everything from target discovery to molecule design and development at scale. 🔍 𝗜𝗻 𝗦𝘂𝗺𝗺𝗮𝗿𝘆 2025 made it clear: GLP-1 innovation, ADC engineering, cell & gene therapy breakthroughs,
Janine Sengstack, Ph.D. - Biocom Skip to main content Search Cancel Select Location Choose a location San Diego Greater Los Angeles Bay Area Seattle Sacramento Washington, D.C. Tokyo Enter your location ZIP Code Submit Location Member Login Career Hub Venture Hub News & Insights Newsroom News Releases Media Resources In the News Economic Impact Report CEO Updates Newsletters Subscribe Regional Policy & Advocacy Group Purchasing LifeLines Innovations Interviews Insights Involvement Past Podcast Episodes About About Us Our Team Board of Directors Careers Contact Our Locations San Diego … ent Member Benefits Career Hub HR Biotech Group (HRBG) Professional Development Fellowship Programs Affiliated Organizations Biocom Institute Generation STEAM Festival of Science & Engineering Join Membership Member Benefits Become a Member Conference & Events Funding & Partnering Group Purchasing Policy & Advocacy Workforce Development International Connections Increase Visibility Community Building Catalyst: Innovators Under 40 CEO/Founder Network Converge … ent Member Benefits Career Hub HR Biotech Group (HRBG) Professional Development Fellowship Programs Affiliated Organizations Biocom Institute Generation STEAM Festival of Science & Engineering Join Member Login Career Hub Venture Hub News & Insights Newsroom News Releases Media Resources In the News Economic Impact Report CEO Updates Newsletters Subscribe Regional Policy & Advocacy Group Purchasing LifeLines Innovations Interviews Insights Involvement Past Podc
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
💸 Miriam Rivera's Ulu Ventures Raises $208M for its Fund IV Subscribe Sign in 💸 Miriam Rivera's Ulu Ventures Raises $208M for its Fund IV FemWealth Issue #197 Anamaria Iuga Feb 16, 2025 ∙ Paid Share Hi FemWealth Friends, In the Spotlight 💸 Co-founded and led by Miriam Rivera , Ulu Ventures raised its fourth fund of $208 million. The Palo Alto, California-based VC firm invests in Seed stage startups across enterprise, fintech, consumer, health, and sustainability. Ulu Ventures © Ulu’s investment thesis is driven by the conviction that diversity is pro… This post is for paid subscribers
RNA Leaders Insights: RNA Therapeutics Breakthroughs | RNA Leaders posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to … secures KRW 110 billion investment from BOLD (L'Oréal Corporate Venture Capital Fund) and Weiss (U.S. Hedge Fund), fueling expansion of its RNA interference platform. 🔗 https://lnkd.in/dqexx4hg ⭐ Moderna receives $50 million to develop mRNA Ebola vaccine against Bundibugyo strain, expanding the potential of mRNA technology in infectious disease prevention. 🔗 https://lnkd.in/eU9hAEbN ⭐ Alnylam Pharmaceuticals pays Inceptive $30 million to transform siRNA design with AI, leve … ther direction: Platform selection should be driven by the intended therapeutic application: • Vaccines may benefit from balancing humoral and cellular immunity. • Protein replacement therapies may prioritize prolonged expression. • In vivo cell engineering applications may require a different optimization profile altogether. 🌟 As the RNA therapeutics field expands beyond conventional mRNA vaccines, comparative studies like this provide valuable guidance for rational platfor
Longevity Market Fundraising Deals (2026) – New Market Pitch Skip to content Home Startup News Blog About Us Contact Us Home Startup News Blog About Us Contact Us Search Cart Item added to your cart View cart Check out Continue shopping All the fundraising deals in the longevity market (from Q1 2025 to Q1 2026) Last updated: 2 April 2026 Download our beautiful pitch about the longevity market In our longevity market deck , you will find everything you need to understand the market The longevity market saw 18 publicly announced funding rounds between Q1 2025 and Q1 2026, totaling nearly $ … oyal raised $22M in a Series B-2 led by Valor Equity Partners and Collaborative Fund to move its canine longevity drug programs forward after an important FDA milestone. And, yes, we do cover most of them in our beautiful pitch about the longevity market . You may also want to check our ranking of the most funded startups in the longevity market as well as our list of the most valued startups . In our longevity market deck , we answer all the common questions from investors a
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Investment and Track Record — VENTURE SCIENCE 0 Skip to Content VENTURE SCIENCE Helix Philosophy Leadership Performance and Portfolio Institutional Investors Family Offices RIAs Contact Open Menu Close Menu VENTURE SCIENCE Helix Philosophy Leadership Performance and Portfolio Institutional Investors Family Offices RIAs Contact Open Menu Close Menu Helix Philosophy Leadership Performance and Portfolio Institutional Investors Family Offices RIAs Contact Our Performance. Over the past decade, Venture Science has invested across multiple funds and special-purpose vehicles spanning deep techn
Quartz - ICYMI: Coinbase CEO's anti-aging startup NewLimit... Facebook Log In Quartz's Post Quartz Verified account June 4 at 8:34 AM · Shared with Public ICYMI: Coinbase CEO's anti-aging startup NewLimit is raising $435 million, tripling its valuation: The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year qz.com NewLimit raises $435M Series C, valuation hits $3.1B All reactions: 1 Like Comment
Junevity Inc. Asset Profile | Preqin Skip to main content Products Our products Preqin Pro Alternative assets data platform Private Markets Research Industry research Term Intelligence Benchmark LPA terms Preqin Benchmarks Industry's leading performance data Preqin Sustainability ESG data and insights Company Intelligence Companies & deals data Enterprise Data Solutions Flexible data delivery solutions Transaction Intelligence A $5.4tn transaction repository Client stories What our clients say Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data Contact us Insights+ Private markets research Homepage Browse reports Search Search the research library Webinar recordings Join conversations with our analysts Meet the analysts Meet the team behind the reports Learn more Learn more about Private Markets Resear … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Insights+ Homepage Search Webinar recordings Meet the analysts Learn more News & content Homepage Events Free Benchmarks Data coverage map Preqin Profiles Preqin Academy Compensation calculator About Who we are Our corporate responsibility Partners Press hub Careers Contact us QuickLinks Our data Asset classes we cover Create a free account Newslett … ed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers. Request demo Junevity Inc. - overview Established 2023 Location San Francisco, CA, US Primary Industry Biotechnology About Junevity Inc. was founded in 2023 in San Francisco, US, specializing in therapies targeting aging-related conditions. The founder's specific background is not available, but the strategic foun … go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more. Sign in Request demo Our Company Who We Are Our Corporate Responsibility Partners
Godfrey Capital - FAMILY OFFICE Profile & Portfolio | Premier Alternatives Exchange Companies Investors Rankings More Toggle theme Investors Godfrey Capital Godfrey Capital Family Office San Francisco, California, United States Godfrey Capital is a family office based in San Francisco, California. The firm's venture investing arm aids the growth of enterprise companies and companies in the big data, financial tech, logistics technology, medical technology, energy and energy technology spaces through advisory roles, board membership, capital investments and influential networking. Over … Capital 's full profile Sign up to view portfolio companies, deal history, fund details, and team — and connect with Godfrey Capital through our brokerage team. Sign Up Free Free access · No credit card required Stay Updated Get insights on private market opportunities and industry trends delivered to your inbox. Subscribe Vero Beach, FL 32963 USA Company Home About Us Team Contact Us Help & FAQ Terms of Service Resources Articles Secondary Transactions RainMaker Sec
The PAI Healthspan Update May 31 – June 13, 2026 PaisanoAI Weekly Subscribe Sign in The PAI Healthspan Update May 31 – June 13, 2026 Your Weekly Guide to Longevity Events, Research, and What Science Says About Living Better, Longer May 31, 2026 ∙ Paid Share Sunday, May 31, 2026 • Vol. 1, No. 2 • Paisano AI Publications Editor’s Note by Bob McVey Welcome to The PAI Healthspan Update Welcome to The PAI Healthspan Update — May 31–June 13, 2026 One week ago, in our inaugural edition, we introduced this column with a promise: science first, context always, hype called out when we see it. This secon
Next-Generation Therapeutics | February Round-Up 2025 We are hiring! Get in Touch 0 Your Cart $ 0.00 USD : Remove Subtotal Pay with browser. Continue to Checkout No items found. Product is not available in this quantity. Who We Serve Industries Clinical Diagnostics Financial Services Pharma & Biotech Research Tools Our Capabilities Market Research AdBoards Competitive Analysis Data Analytics KOL Identification Market Landscaping and Sizing Patient / Diagnostic Journey Mapping Surveys / Trackers / ATUs Voice-of-Customer Research Strategy Consulting Biomarker and Diagnostics Strategy Custome … oduct Specification Mapping Revenue Projection Target Identification Technology Application Identification View Client Results Data & Platforms Data & Platforms Market Reports Ad Boards DxBooks Transcripts Overview of Data Products View All Products About Overview Overview & Mission Culture Locations Team Careers Why DeciBio Open Positions Interviewing Hiring FAQs Insights 0 Your Cart $ 0.00 USD : Remove Subtotal Pay with browser. Continue to Checkout No items fou … ive Therapies has announced FDA clearance of its Investigational New Drug (IND) application for BRTX-100, a cell-based therapy, for a Phase 2 trial in chronic cervical discogenic pain. BRTX-100 is the first stem cell product candidate cleared for evaluation in cervical degenerative disc disease. The planned double-blind, sham-controlled, randomized study will assess the safety and preliminary efficacy of intradiscally injected BRTX-100. This clearance expands the company' … ADECTRIS | Regulatory The U.S. FDA approved the supplemental Biologics License Application (sBLA) for ADCETRIS in combination with lenalidomide and a rituximab product for adult patients with relapsed or refractory large B-cell lymphoma (LBCL) who have failed two or more lines of systemic therapy who are not eligible for autologous hematopoietic stem cell transplantation or chimeric antigen receptor T-cell therapy. This approval is relevant to thousands of patients annually
Start - HEALTH CAPTAINS INSTITUTE Skip to main content News Events Join Club Store Donate Login INSTITUTE FACULTY DEVISIONS HEALTHY LONGEVITY BLUE ZONES ONE HEALTH Toggle Menu INSTITUTE LEADERSHIP PATRONAGE TRUSTEES PRESIDENT CHAIRS PROGRAM COMMITEES INSTITUTE COLLEGE NAVIGATION MEDICINE 4.0 CARE 4.0 HEALTH 4.0 INSTITUTE FACULTY COLLEGE FACULTY INSTITUTE COOKBOOK VISION & MISSION SICKCARE HEALTHCARE LIFECARE FACULTY MEDICAL BOARD ADVISORY BOARD FACULTY TRUSTEES AMBASSADORS DEVISIONS DEVISIONS BUSINESS DEVELOPEMENT STRATEGY STUDIES COMPETITIVE STUDIES CONVERGENCE STUDIES SYNCHRONIZATION ST … a comprehensive longevity strategy that connects scientific discovery, medical application, and economic sustainability—advancing a future where more people live longer in good health. Read More Divisions Overview DIVISIONS OVERVIEW DEVISIONS BUSINESS DEVELOPEMENT… Division Overview “The challenges are too big for any one single organization.” Guided by this shared understanding, THE HEALTH CAPTAINS INSTITUTE serves as a dynamic think-and-do-tank platform for interdis
Emails Archive - Page 18 of 29 - Biocom Skip to main content Search Cancel Select Location Choose a location San Diego Greater Los Angeles Bay Area Seattle Sacramento Washington, D.C. Tokyo Enter your location ZIP Code Submit Location Member Login Career Hub Venture Hub News & Insights Newsroom News Releases Media Resources In the News Economic Impact Report CEO Updates Newsletters Subscribe Regional Policy & Advocacy Group Purchasing LifeLines Innovations Interviews Insights Involvement Past Podcast Episodes About About Us Our Team Board of Directors Careers Contact Our Locations Sa … ent Member Benefits Career Hub HR Biotech Group (HRBG) Professional Development Fellowship Programs Affiliated Organizations Biocom Institute Generation STEAM Festival of Science & Engineering Join Membership Member Benefits Become a Member Conference & Events Funding & Partnering Group Purchasing Policy & Advocacy Workforce Development International Connections Increase Visibility Community Building Catalyst: Innovators Under 40 CEO/Founder Network Converge … ent Member Benefits Career Hub HR Biotech Group (HRBG) Professional Development Fellowship Programs Affiliated Organizations Biocom Institute Generation STEAM Festival of Science & Engineering Join Member Login Career Hub Venture Hub News & Insights Newsroom News Releases Media Resources In the News Economic Impact Report CEO Updates Newsletters Subscribe Regional Policy & Advocacy Group Purchasing LifeLines Innovations Interviews Insights Involvement Past Podc … re than previously announced —19.8 percent instead of 17.6 percent. The updated proposal is scheduled to be heard at Council on September 19; officials didn’t provide estimates of the impact on monthly bills for business customers. They said rate increases are needed to pay for upgrades to customer service, infrastructure maintenance, and capital projects such as Pure Water. Fallbrook and Rainbow water districts’ approval to leave the San Diego County Water Authority could al … hips, and attend networking sessions. Click here for more information and apply by September 8 for 1:1 meetings. This event will take place in the Bay Area this November, and selected companies must be physically present. Talent & Workforce Job Seeker Informational Session – Future Panelists Wanted Biocom Institute in c
We're excited to announce that Junevity has entered a Catalyze Agreement with Eli Lilly and Company ExploR&D to support our RESET Platform efforts to discover novel siRNA targets for Parkinson’s… | Janine Sengstack LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your cho
%PDF-1.7 %���� 481 0 obj > endobj xref 481 55 0000000016 00000 n 0000002769 00000 n 0000002914 00000 n 0000002950 00000 n 0000004138 00000 n 0000004617 00000 n 0000005261 00000 n 0000005952 00000 n 0000006584 00000 n 0000006708 00000 n 0000007277 00000 n 0000007314 00000 n 0000007788 00000 n 0000007880 00000 n 0000007992 00000 n 0000008097 00000 n 0000009130 00000 n 0000010098 00000 n 0000010212 00000 n 0000010522 00000 n 0000010824 00000 n 0000011851 00000 n 0000012400 00000 n 0000012843 00000 n 0000013369 00000 n 0000014022 00000 n 0000014667 00000 n 0000015231 00000 n 0000015778 00000 n 000 … �����~��V��,���������p>ږ�e@��(�R�������T��"M��;R� ��� �����$Mq��.�����T�� ��RFp����P�$���x��qWn�j� �ڷ%a���8�Z��e�,�ԛJO �WK� �mIW��!f�~G� ��A ���H��WV,K�N/jr*v�� ��E(+o�{\�%iXK�/ mx ɀ�dyg��Սi�� �ת����Dqe�]�����Xa�]Y�*L�ԝ����n�҅W�-�ef�5*zdd�a�)���S�\J趓�6�����:�s��wI��1 � ��B����l�"�� � 3����0 ��L���.� �q� d��O1�Zu9�y(aI*I��0 �|�?P �`?��@~� ?� ܘ �F�h{OӐi�J��z�e��:C���6��j3�6C d���k�@ ,�>���u=�7�SP�U���)s]�Z�� Z)���) ��5!'�e��ˋ���� �ڴ��Ѹ … 4888e2b5ad8 xmp.did:ab0aaac6-1858-4a34-ad89-485fec28e48b default converted from application/x-indesign to application/pdf Adobe InDesign 20.0 (Macintosh) / 2025-06-02T13:27:34-07:00 application/pdf Adobe PDF Library 17.0 False endstream endobj 480 0 obj > endobj xref 0 481 0000000000 65535 f 0000907083 00000 n 0000908513 00000 n 0000908554 00000 n 0000908690 00000 n 0000908826 00000 n 0000908960 00000 n 0000909094 00000 n 0000912188 00000 n 0000930341 00000 n 0000931147 00000
CDN Digital - LIVING LONGER AND BETTER WITH REGENERATIVE... Facebook Log In CDN Digital's Post
Junevity | Substack Junevity Subscribe Sign in Home Archive About Junevity collaboration with Eli Lilly ExploR&D in Parkinson's Disease Leverages Junevity's RESET Platform to identify novel siRNA targets for Parkinson's Jun 2 • Junevity 1 Publication of the first research to show repression of a single transcription factor can reverse cell aging Junevity founders publish their work in PNAS in January 2026 Feb 5 • Junevity 1 1 Junevity expands Seed funding to $20M for cell reprogramming with siRNA New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for
RNA Therapeutics Weekly – Week 22/2026 LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie Po
Janine Sengstack Presents siRNA Therapeutic Breakthrough at American Aging Association Meeting | Junevity posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Co
RESET Platform — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PIPELINE Pioneering siRNA therapeutics to restore gene networks, starting with cardiometabolism JUN_01 for residual inflammation in Type 2 diabetes Junevity’s lead program, JUN_01 , is a novel liver-targeted siRNA to treat the millions of Type 2 diabetes patients with residual inflammation and cardiovascular risk. In non-human primate studies,
PRESS RELEASE — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PRESS RELEASE May 27 Written By Rob Cahill BUSINESS WIRE: Junevity, a biotechnology company on a mission to extend lifespan and healthspan with siRNA (silencing RNA) therapeutics, today announced co-founder and chief scientific officer Dr. Janine Sengstack will be presenting the first ever data demonstrating that siRNA therapeutics can restore g
Hitting the Reset Button on Cellular Aging | The Bio Report Cancel Home Subscribe Profile The Bio Report https://feed.podbean.com/thebioreport/feed.xml Share RSS The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy. The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy. Episodes Wednesday Oct 29, 2025 Hitting the Reset Button on Cellular Aging Wednesday Oct 29, 2025 Wednesday Oct 29, 2025 Transcr
Junevity - Drug Discovery World (DDW) Drug Discovery World (DDW) About Us | Subscribe Free | Media Info | Contact Us | Log In News Exclusive Content Features Opinion Market Reports Trends & Analysis Start-up Zone DDW eBooks Business & Investment Regulatory Events DDII Events Series Other Events Webinars Resources Magazine Digital Issues Archive Multimedia Videos Podcasts Topic filter: Cancer Research Immunology / Virology & Vaccines Advanced Therapies Neuroscience Multiomics Artificial Intelligence Automation & Robotics Therapeutic Antibodies Microbiome Drug Discovery Cell Science About Us
Reprogramming the cell from aged to healthy with siRNA - Dr. Janine & Rob (Junevity) - Free Radicals | Podcast on Spotify
Junevity's AI-Powered Rejuvenation Therapy | Daniel Shur posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Linke … vani, a molecular biologist with a background in pharmaceutical engineering, an award winning gut health expert and founder and CEO of Alba Health, a company on a mission to prevent chronic diseases through gut health science. In this episode, Nora shares: - How getting told that she would need to use cortisone for the rest off her life to manage severe eczema led her to the extensive research that resulted in her becoming an expert in the gut microbiome - The anti-inflammato … e Miller and Diane Miller, the incredible couple behind the Misophonia Research Fund . They’ve basically built the field of misophonia research from the ground up, now funding dozens of researchers worldwide working on everything from brain imaging to AI sound filtering. We talk about what it’s really like accelerating medical research, their hopes for bringing young scientists into the field, why open data sharing matters so much. The Misophonia Podcast …more 26 1 Comment Li
Excellent podcast on the PhD work by Janine Sengstack and Junevity ‘s “cell reset” science and drug development | Rob Cahill LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to jo … uthor 9 Mistakes Managers Make with Remote Employees Rob Cahill 9y How One Acre Fund Trains Managers a World Away Rob Cahill 9y What Does it Mean to “Manage Your Manager?” Rob Cahill 9y Explore content categories Career Productivity Finance Soft Skills & Emotional Intelligence Project Management Education Technology Leadership Ecommerce User Experience Recruitment & HR Customer Experience Real Estate Marketing Sales Retail & Merchandising Science Supply Chain Mana
Biotech raises $10m to address ageing at a cellular level - Drug Discovery World (DDW) Drug Discovery World (DDW) About Us | Subscribe Free | Media Info | Contact Us | Log In News Exclusive Content Features Opinion Market Reports Trends & Analysis Start-up Zone DDW eBooks Business & Investment Regulatory Events DDII Events Series Other Events Webinars Resources Magazine Digital Issues Archive Multimedia Videos Podcasts Topic filter: Cancer Research Immunology / Virology & Vaccines Advanced Therapies Neuroscience Multiomics Artificial Intelligence Automation & Robotics Therapeutic Antibodie
Backing Junevity, with the founding team of John Hoekman, Janine Sengstack, Rob Cahill, and all of the outstanding Junevity team members has been one of the easiest decisions I have made as an early… | Jason Godfrey LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at
Hitting the Reset Button on Ce…–The Bio Report – Apple Podcasts Search Home New Top Charts Search 29 October 2025 43 min Hitting the Reset Button on Cellular Aging The Bio Report Play Transcription factors control the genetic programs that maintain cellular balance, but while they have been seen as compelling targets for aging-related disease, they have long been considered “undruggable.” Junevity’s RESET platform leverages large-scale human omics data and AI models to pinpoint key transcriptional drivers of disease and to design siRNA therapies that restore healthy gene expression. We spoke
PODCAST — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PODCAST May 20 Written By Rob Cahill Dr. Janine Sengstack shares her scientific journey and inspiration with The Alliance for Longevity’s Dr. Brenda Eap. READ MORE Rob Cahill Previous Previous PUBLICATION Next Next CONFERENCE ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT LINKEDIN All Rights Reserved © 2026 Junevity Inc.
PODCAST: TRANSLATING AGING — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PODCAST: TRANSLATING AGING Apr 2 Written By Rob Cahill What if we could restore cells from a diseased state to health without changing their identity? This week Translating Aging talks with Janine Sengstack , CSO and co-founder of Junevity , which recently raised a $10 million seed round. Junevity uses its RESET platform to identify
Careers — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT WE CREATE BREAKTHROUGH THERAPIES FOR HUMAN LONGEVITY Junevity is looking for world-class people ready to tackle challenging problems in bioinformatics, drug discovery, therapeutic development, and company-building. On our 80th (and 120th) birthdays, we will remember our time at Junevity as our life’s work. This will be the work we are most proud of, w
Translating Longevity Biology into Therapeutics for Age-Related Diseases - BIO International Convention 2026 Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! June 7-10 | Philadelphia Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Glance FAQs International Visitors Why Attend Visa Invitation Letter Request Tips for International Visitors Share On Social Media For Press Media Resource Center Media Registration Engaging with the Media Request Media List … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … Amgen Genentech Boehringer Ingelheim Lilly Novo Nordisk Sanofi Academic Campus Apply for Academic Campus Exhibition Directory and Map Event Directory Exhibitor List Exhibitor In-Booth Events Event Map Exhibition Hours Exhibition Reception BIO Booths BIO Business Solutions® Pavilion BIO Member Lounge Networking BIO Receptions Other Events Social Spotlight Events Affiliate Events Application Special Experiences 5K and 1 Mile Course BIO Gives Back Headshot Lounge Matchday Loung
RESET Platform — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PIPELINE Pioneering siRNA therapeutics to restore gene networks, starting with cardiometabolism JUN_01 for residual inflammation in Type 2 diabetes Junevity’s lead program, JUN_01 , is a novel liver-targeted siRNA to treat the millions of Type 2 diabetes patients with residual inflammation and cardiovascular risk. In non-human primate studies,
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Instagram Instagram Log In Sign Up Close Never miss a post from cytonics_corporation Sign up for Instagram to stay in the loop. Sign up Log in cytonics_corporation • Follow More options cytonics_corporation 3w We're going live! Our Cytonics Investor Webinar is happening at 1pm PT / 4pm ET today. If you've been following our progress, considering an investment, or simply want to learn more about CYT-108 and our mission to change the future of osteoarthritis treatment, this is your opportunity to hear directly from CEO Joey Bose and ask questions live. Last-minute registrations are sti
RESET Platform — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT RESET PLATFORM The Junevity RESET Platform develops novel therapeutics to restore gene networks with human disease data, machine learning and siRNA. Transcriptional dysregulation drives disease PROBLEM Diseases related to longevity and aging see profound gene dysregulation, which is often overlooked in drug discovery due to its complexity. Rese
Synthetic Design Lab Emerges with $20M to Advance Next-Generation ADCs - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Synthetic Design Lab Emerges with $20M to Advance Next-Generation ADCs April 24, 2025 | 5 min read Twitter LinkedIn Facebook Email Print Company is led by cancer immunotherapy and protein engineering pioneer Daniel S. Chen, M.D., Ph.D. SYNTHBODY ™ platform increases targeted payload delivery ≥ 10x compare … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
PharmiWeb.com – Thank you 1998 – 2026 AFTER TWENTY–EIGHT YEARS Thank you. Thank you for building PharmiWeb.com Since 1998, this community has helped people find opportunities, build careers, and connect across the industry. As we close this chapter, we do so with gratitude and pride in what we created together. For everyone who found an opportunity here, from entry-level roles to VP positions , and everything in between. And for every advertiser, partner, reader, and every member of the PharmiWeb team since 1998. We were there at the beginning of the dot-com era, even beating
59th Annual Recent Advances in Neurology 2026 - University of California, San Francisco - Continuing Education (CE) Neurology</Profession><Profession>Pediatrics</Profession><Profession>Pediatric Critical Care Medicine</Profession><Profession>Pediatric Emergency Medicine</Profession" /> {1} ##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1} ##LOC[OK]## ##LOC[Cancel]## UCSF Office of CME Home Sign In Live Courses On Demand Grand Rounds About Us Help {1} ##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1} ##LOC[OK]## ##LOC[Cancel]## UCSF Employees and Affiliates – Please use your UC … Forgot Your Password? Forgot Your Password? Enter your Email address and click submit to have a login reset link sent to you. Back to Login {1} ##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1} ##LOC[OK]## ##LOC[Cancel]## Create an Account: (All fields are required) Email: First Name: Last Name: Password: Password: Password Requirements Must be between 8 and 16 characters in length Must Contain at least 1 upper case character Must Contain at least 1 lower case character Must c … ve case-based sessions. . Objectives As a result of the education, I intend to: Apply new concepts to epilepsy, multiple sclerosis, aging and movement disorders in practice; Recognize and select diagnosis and management of stroke, multiple sclerosis, headache, dementia, and apply best practices for their management. Improve team-related clinical skills and team performance Learn with other health care professionals in a way which will helps the learner become a more effective … r to fully participate in this event please let us know during registration, or submit a learner support ticket with as much advance notice as possible and at least 7-10 days in advance of the event. UCSF Land Acknowledgment Statement We would like to acknowledge the Ramaytush Ohlone people, who are the traditional custodians of this land. We pay our respects to the Ramaytush Ohlone elders, past, present, and future, who call this place, the land that UCSF sits upon, their ho … Adjepong, MD UCSF Faculty Nothing to disclose Liza H Ashbrook, MD UCSF Faculty Grant or research support-Alkermes|Grant or research support-Neurocrine Ian Bledsoe, MD, MS UCSF Faculty Nothing to disclose Vanja C Douglas, MD Professor of Clinical Neurology UCSF Faculty Nothing to disclose John W Engstrom, MD Professor of Neurology UCSF Faculty No
Junevity – Reset gene networks to reverse disease 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Reset gene networks to reverse disease TRANSCRIPTIONAL DAMAGE Many complex and age-related diseases exhibit widespread gene dysregulation. However, most drug discovery only targets a single dysregulated gene. BREAKTHROUGH SCIENCE Junevity founders were the first to show that repression of a single transcription factor can restore gene networks to a heal
Junevity Jobs | BioBae Bio Bae Browse Jobs Companies For Employers Home / Companies / Junevity J Junevity Biotechnology 📍 San Francisco , CA Junevity develops long-lasting siRNA therapies using its RESET platform for cell reprogramming, aiming to extend healthspan and lifespan. Visit website → View careers page → Open Positions at Junevity 0 positions available No open positions at the moment Check back later for new opportunities! Bio Bae The premier job board for biotech, pharma, and life sciences professionals. For Job Seekers Browse Jobs Remote Jobs Companies For Employers Post a Job Spon
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Scientist Spotlight EP 7: Dr. Janine Sengstack - Alliance for Longevity Initiatives Skip to content Dr. Mehmet Oz’s Opening Remarks at A4LI’s 2025 Congressional Briefing Join A4LI Become a Member Become a Sponsor Get Involved Our Advocacy Publications Longevity Science Caucus Podcasts H-SPAN Podcast Scientific Spotlights About Events A4LI H-SPAN Summit D.C. Past Events A4LI Longevity Investors Summit A4LI 2025 D.C. Summit Recap DC Fly-In 2024 Geroscience Education Reception LogIn Join A4LI Become a Member Become a Sponsor Get Involved Our Advocacy Publications Longevity Science Caucus Podcasts … he small business community, Kesselring received the 2022 SBA District Director Award for his work supporting small business owners across the country through SCORE and affiliated organizations, with a particular focus on helping businesses establish an online presence during the COVID-19 shutdown. He is also an alumnus of the Goldman Sachs 10,000 Small Businesses program through Babson College. Kesselring is currently a Republican candidate for State Representative represent … a Therapeutics, Dr. Freund has secured over $50M in financing and pioneered the application of targeted biologics to deplete the pathogenic cells that drive chronic diseases and aging. Previously, as a senior leader at Calico Life Sciences, Dr. Freund founded and managed an R&D team with the mission of merging computational and experimental biology to develop interventions that slow or reverse aspects of aging. He launched and led several therapeutic programs, notably spe … s Fiona Miller is a Managing Partner at quadraScope Ventures, a venture capital fund focusing on early-stage investments in the longevity biotechnology sector. She is a serial entrepreneur with over 40 years of experience in technology entrepreneurship and venture capital, previously founding and leading three technology companies to successful exits. Natalia Mitin CEO Sapere Bio Dr. Natalia Mitin is the co-founder, president, and CEO of Sapere Bio, a longevity technology com … etta and Arivale. His many national and international awards include the Lasker Prize, the Kyoto Prize, and the National Medal of Science. Currently, he is the CEO of Phenome Health, Co-Founder and Professor at the Institute of Systems Biology in Seattle, and Co-Director, Center for Human Healthspan, Chief Innovation Officer and Distinguished Pro
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Janine Sengstack - BIO International Convention 2026 Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! June 7-10 | Philadelphia Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Glance FAQs International Visitors Why Attend Visa Invitation Letter Request Tips for International Visitors Share On Social Media For Press Media Resource Center Media Registration Engaging with the Media Request Media List Press Releases Stay in Touch Contact Us Join our mailin … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … Amgen Genentech Boehringer Ingelheim Lilly Novo Nordisk Sanofi Academic Campus Apply for Academic Campus Exhibition Directory and Map Event Directory Exhibitor List Exhibitor In-Booth Events Event Map Exhibition Hours Exhibition Reception BIO Booths BIO Business Solutions® Pavilion BIO Member Lounge Networking BIO Receptions Other Events Social Spotlight Events Affiliate Events Application Special Experiences 5K and 1 Mile Course BIO Gives Back Headshot Lounge Matchday Loung
Junevity’s $10M Seed Round: A Major Step for Longevity Science Categories Companies Unicorns Interview Blog Newsletter Contact SaaS Fintech HealthTech Cleantech Financial HRTech Blockchain Consumer Mobility B2B Events Newsletter Contact Aerospace Financial AI Fintech B2B Funding news Blockchain HealthTech CleanTech HRTech Consumer Tech Mobility Crypto Robotics Cybersecurity SaaS Events How Technology Is Changing Consumer Awareness Around Car Finance June 26, 2026 Patronus AI Secures $50M to Build AI Training Simulations June 26, 2026 Hera Raises $27M Series A Led by Bain Capital Ventures June
- LONGEVITY GLOBAL Skip to content LONGEVITY GLOBAL SF | NYC | UAE | BOS | SD | ATX | CO | HYD | CHI | LON | PHX | LA | DEU Menu + × expanded collapsed Events Calendar of longevity events Brain Optimization Summit 2026 Longevity Global Summit 2026 AI x Longevity Summit (NYC) Aging Code Summit 2026 Longevity Innovation Forum (SD) Event Photos Community Become a member Community Chapters Longevity CO Longevity SF Longevity SD Longevity NYC Longevity BOS Longevity Global ATX Longevity CHI Longevity MEL Longevity DEU Longevity LON Resources About Substack YouTube Discount Marketplace Jobs Bo … or government representative. Interested in showcasing your products/services? Apply to Sponsor OUR SPEAKERS See below for our confirmed speakers for 2026. More updates are coming soon. Eric Verdin, MD President & Professor Buck Institute Janine Senstack, PhD CSO and Co-founder Junevity Krista Ramonas , MD Founder, CEO & Physician LabXMD Ronjon Nag, PhD President, Adj. Professor R42 Group, Stanford Matthew “Oki” O’Connor Co-CEO Cyclarity Therapeutic … 6 Summit and a feature article in the Longevity Global Substack and Newsletter. Apply to pitch CONGRATS TO OUR 2025 PITCH COMPETITION WINNER! David Scieszka, PhD Co-founder and CEO Vertical Longevity Therapeutics CONGRATS TO OUR 2024 PITCH COMPETITION WINNER! Michael Florea, PhD Co-founder and CEO Olden Labs CONGRATS TO OUR 2023 PITCH COMPETITION WINNER! Robert Lustig, MD MSL Co-founder and CMO Biolumen WATCH PRESENTATIONS Interested in the latest in cutting edge longevity sc … ube Channel . PRESENT A POSTER Abstract submissions are due by December 1, 2026 Submit Abstract SPONSORS MEDIA SPONSORS ← Back You are Subscribed! Thanks for signing up for Longevity Global Newsletter. Email Subscribe to our Newsletter Submitting form Δ X LinkedIn YouTube Donate Become a member [email protected] Privacy Policy LONGEVITY GLOBAL , Newsletter Subscribe to the Longevity Global Newsletter Sign up for our email newsletter for longevity events and news. Ema
Junevity Is Silencing RNA to Treat Obesity and Diabetes Back to lifespan Home Login Return to Lifespan Homepage Donate Login News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep Diet Financial Blockchain Investing Advocacy Policy Public Outreach LRI News Interviews Op-Ed Editorial Editor’s Pick Rejuvenation Roundup Press Releases News Outlet Research Biology of Aging Artificial Intelligence Decentralized Science Biomarkers Lifestyle Interventions Supplements Mindfulness Exercise Sleep
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Junevity – Reset gene networks to reverse disease 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Reset gene networks to reverse disease TRANSCRIPTIONAL DAMAGE Many complex and age-related diseases exhibit widespread gene dysregulation. However, most drug discovery only targets a single dysregulated gene. BREAKTHROUGH SCIENCE Junevity founders were the first to show that repression of a single transcription factor can restore gene networks to a heal
PRESS RELEASE — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PRESS RELEASE Dec 3 Written By Rob Cahill Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA Goldcrest Capital and Godfrey Capital led new funding to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studies. JUN_01 would be the first ever candidate to reprogram metabolism with siRNA, and
Fun conversation covering cell reprogramming, Junevity's approach, longevity bottlenecks and how we got into longevity biotech. | Rob Cahill LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By cli … uthor 9 Mistakes Managers Make with Remote Employees Rob Cahill 9y How One Acre Fund Trains Managers a World Away Rob Cahill 9y What Does it Mean to “Manage Your Manager?” Rob Cahill 9y Explore content categories Career Productivity Finance Soft Skills & Emotional Intelligence Project Management Education Technology Leadership Ecommerce User Experience Recruitment & HR Customer Experience Real Estate Marketing Sales Retail & Merchandising Science Supply Chain Mana
About Me - Computational Aging Home The Big Goal About Me All Posts ☰ Edit Page Manage Logout Login Learn more about Posthaven Computational Aging How can we live far longer, healthier lives? How can data + AI help? How to bring the benefits to the world? About Me I work on progressing the science of aging and age-related disease. I hope we can all live much longer and healthier than we do today. Age-related diseases are awful. They are responsible for 2/3 of worldwide deaths every year. Think of dementia, cancer, heart disease, diabetes, frailty, and more. They’re coming for all of us. The ne
PODCAST: THE BIO REPORT — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PODCAST: THE BIO REPORT Oct 31 Written By Rob Cahill John Hoekman, co-founder and CEO of Junevity, discusses the role of transcription factors in healthy biology and aging-related disease, the company’s AI-driven platform for identifying dysregulated transcription factors, and its lead programs targeting type 2 diabetes and obesity. Jo
I’m happy to share that I’m starting a new position as Chief Scientific Officer and President at Junevity. Junevity is rewinding diseases of aging with novel transcription factor medicines. Based on… | John Hoekman | 40 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update yo
News — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT NEWS Junevity was founded out of UCSF in 2023 to extend human lifespan and healthspan. Follow our journey by following us on LinkedIn or subscribing to our newsletter . Rob Cahill 6/10/26 Rob Cahill 6/10/26 ADVISOR APPOINTMENTS Junevity appoints four key siRNA scientists, leaders and innovators as hands-on advisors, together known as Sunrise BioVentures.
RESET Platform — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT RESET PLATFORM The Junevity RESET Platform develops novel therapeutics to restore gene networks with human disease data, machine learning and siRNA. Transcriptional dysregulation drives disease PROBLEM Diseases related to longevity and aging see profound gene dysregulation, which is often overlooked in drug discovery due to its complexity. Rese
Cell Reset Therapeutics to Ext… - Translating Aging - Apple Podcasts Search Home New Top Charts Search April 2, 2025 37 min Cell Reset Therapeutics to Extend Healthspan and Lifespan (Janine Sengstack, Junevity) Translating Aging Play Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what they term "Cell Reset therapeutics." The company recently secured $10 million in seed funding. In this episode, Chris and Janine explore the innovative platform Janine developed during her Ph
Podrían haber hallado cómo rejuvenecer células y frenar el envejecimiento Buscar Newsletter Club Esquire Moda Tecnología Cuidados hombre Actualidad Cine TV Libros Música Gastro Motor Viajes Buenas compras online Revista Aviso de Privacidad Síguenos Política de Cookies Otras Ediciones Aviso de privacidad Términos de uso Skip to Content Moda Club Esquire Readers Club Esquire Drinks Club Esquire Watches Cuidados SUSCRÍBETE Iniciar Sesión Getty Images Ciencia Unos científicos podrían haber descubierto cómo rejuvenecer las células y frenar el envejecimiento Unos científicos podrían haber descubiert … mentación pueden variar, según Li. Un equipo de investigadores, entre ellos Li, fundó la empresa Junevity Inc. para llevar sus hallazgos a la práctica clínica, centrando sus esfuerzos en enfermedades relacionadas con la edad. Por supuesto, la biología humana difiere de la de los ratones en muchos aspectos importantes. Por ello, será necesario realizar mucha más investigación sobre la seguridad de un tratamiento a largo plazo antes de que este descubrimiento pueda aplicarse a
Scientists De-Aged Cells and Made a Whole Liver Younger, a New Study Shows Search Newsletter Pop Mech Pro Subscribe Home and DIY Power Tools Cars Technology Military Science Adventure Sci-Fi Airplanes Space Gifts Deals Visual Stories Promotions Shop Follow My Bookmarks Privacy Notice Terms Of Use Skip to Content Newsletter sign in Subscribe Search sign in Subscribe Science Home & DIY Technology Gear Reviews Military Transportation Culture & Curiosities About My Bookmarks Newsletter Privacy Notice Terms Of Use sign in Subscribe Science Home & DIY Technology Gear Reviews Military Tra
Cell reprogramming for longer, healthier lives - Blog | OpenAI Academy OpenAI Academy Search SIGN IN Home Events Courses Content Communities What's new Stories Work Education Small business Nonprofits Government News organizations Help Home Events Courses Content Communities What's new Stories Work Education Small business Nonprofits Government News organizations Help Article January 6, 2026 Cell reprogramming for longer, healthier lives # Developers & Builders # Workplace & Business # ChatGPT # Awareness # Work A 10-person biotech team uses OpenAI models to cut drug-discover
Cellular ageing could be reversed, research reveals - Drug Discovery World (DDW) Drug Discovery World (DDW) About Us | Subscribe Free | Media Info | Contact Us | Log In News Exclusive Content Features Opinion Market Reports Trends & Analysis Start-up Zone DDW eBooks Business & Investment Regulatory Events DDII Events Series Other Events Webinars Resources Magazine Digital Issues Archive Multimedia Videos Podcasts Topic filter: Cancer Research Immunology / Virology & Vaccines Advanced Therapies Neuroscience Multiomics Artificial Intelligence Automation & Robotics Therapeutic Antibodies Micr … re broad for cell reprogramming and rejuvenation, and the platform approach can apply to many cell types, tissues and age-related diseases.” Bruno Quinney, Content Team, DDW Related articles This week in Drug Discovery (12 – 16 January) 16 January 2026 • Bruno Quinney New drug for obesity reduced weight gain by 32% 18 October 2024 • Diana Turner Resources Webinars Webinar – Toward Explainable Affinity Maturation: Combining Deep Learning and Physics-based Mutation
Press Release Service: Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging - CRISPR Medicine Logo mobilemenu close CMN Live Home Clinical Trials CMN DB 2.0 CRISPRMED CRISPRMED24 CRISPRMED25 CRISPRMED26 WDC CRISPRMED26 Contest CRISPRMED26 Conference Kit CRISPRMED27 CRISPRMED Website Policies EGMEDC CMN Intelligence Webinars CMN Webinars On-demand - All CMN Webinar - Disrupting the Care of Cardiovascular Disease With Single-Course Gene Editing Medicines CMN Webinar - Taking the Guesswork Out of Drug Development: CRISPR-Select Validates Dr … re broad for cell reprogramming and rejuvenation, and the platform approach can apply to many cell types, tissues and age-related diseases,” said Dr. Hao Li, a UCSF Professor of Biochemistry and Biophysics and Director of UCSF Hillblom Center for Biology of Aging. Dr. Sengstack’s breakthrough research led to the founding of Junevity to bring siRNA reprogramming therapeutics to patients. The proprietary Junevity RESET platform uses omics, genetic linkages, machine learning and
Junevity lands more funding for siRNA-powered cellular reprogramming Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search DiamiR, AlzLabs team up … ghlights new GLP-1 care model GARM Clinic debuts world’s first Klotho longevity residency You might also like Scribe lands $25m to advance heart disease gene therapies ŌURA-LillyDirect collab highlights new GLP-1 care model GARM Clinic debuts world’s first Klotho longevity residency Peers Capital bets on prevention before the pivot NorthStrive eyes emerging GLP-1 opportunity: muscle preservation Danny Sullivan Danny has worked in technology communications for more than 20 yea
Junevity, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 24 Feb 2026 Junevity, Inc. Holding Company | 2023 | California, United States | < 10 | www.junevity.com Holding Company | 2023 | California, United States | < 10 | www.junevity.com Last update 24 Feb 2026 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Tags Endocrinology and Metabolic Disease Other Diseases siRNA Disease domain score A glimpse into the focused therapeutic areas No Data Technol … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data
BioSpace 40 Under 40 - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Ev … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Introducing BioSpace’s 2025 40 Under 40 Winners Congratulations to our inaugural cohort. These young leaders hail from a range of business functions and highlight the values 40 Under 40 is designed to celebrate. BioSpace’s 40 Under 40 honors 40 exemplary biotech and pharma professionals who have distinguished themselves in their com … es and announcements regarding BioSpace ‘s 40 Under 40. Email (Required) Submit About BioSpace’s 40 Under 40 BioSpace’s 40 Under 40 to honors 40 exemplary biotech and pharma professionals who have distinguished themselves in their companies and their field. All under the age of 40, these young leaders already demonstrate our industry’s values of innovation, impact and commitment to improving outcomes for patients. Eligibility Guidelines In order to be eligible, the nom … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer O … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA December 3, 2025 | 3 min read Twitter LinkedIn Facebook Email Print New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studies JUN_01 woul … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting May 27, 2026 | 3 min read Twitter LinkedIn Facebook Email Print The company’s co-founder will deliver an oral presentation with the first ever data showing an siRNA therapeutic can restore g … of safety issues in high-dose toxicology studies in rats and non-human primates Application of the Junevity RESET Platform to neurodegeneration, based on over a billion RNA-seq data points in the brains of healthy vs. Parkinson’s Disease patients, to identify novel targets for siRNA therapeutic development To progress the neurodegeneration efforts, Junevity has entered into a Catalyze Agreement with Lilly ExploR&D to support the company’s RESET Platform discovery of novel … bsp; 2 min read · Tristan Manalac Podcast AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more June 24, 2026 · 1 min read · Jef Akst China BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech June 24, 2026 · 2 min read · Annalee Armstrong BioSpace at BIO to find out" href="https://www.biospace.com/drug-development/can-adcs-be-kin … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Junevity Announces First Peer-Reviewed Research Showing Single-Target Repression Can Reprogram Cellular Aging January 12, 2026 | 4 min read Twitter LinkedIn Facebook Email Print Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gen … re broad for cell reprogramming and rejuvenation, and the platform approach can apply to many cell types, tissues and age-related diseases,” said Dr. Hao Li, a UCSF Professor of Biochemistry and Biophysics and Director of UCSF Hillblom Center for Biology of Aging. Dr. Sengstack’s breakthrough research led to the founding of Junevity to bring siRNA reprogramming therapeutics to patients. The proprietary Junevity RESET platform uses omics, genetic linkages, machine learning and … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Introducing Junevity: Cell Reset for Longevity with siRNA Junevity Subscribe Sign in Introducing Junevity: Cell Reset for Longevity with siRNA Co-founders John Hoekman, Janine Sengstack, Rob Cahill Junevity Feb 13, 2025 1 Share Today is another step towards longer, healthier lives. It all started back in 2017 when Janine’s PhD advisor at UCSF, Dr. Hao Li , asked her, “I have an idea for a PhD project for you to lead… but it’s high risk. Would you be interested?” Thanks for reading Junevity! Subscribe for free to receive new posts and support my work. Subscribe With much hesitation, Janine said
Minds, Medicine & Machines: AI and the Future of Healthcare Skip to content Join Login Events & Content Library Calendar of Events Content Library Financial Perspectives Podcast Other Events in the Industry Past Events August 21 | Burlingame Join fellow investment professionals for a day of friendly competition, great food, and unbeatable networking. Learn More Membership Become a Member Member Benefits Volunteer Opportunities Professional Development Career Resources Professional Credentialing Displaying your Designation on Social Media Candidate & University Programs CFA Program Resources Un … n Horowitz (a16z) where she leads investments for the firm’s bio + health fund across biotech, life sciences software, and digital health, with a focus on companies leveraging unique technologies and datasets to advance drug development, personalized medicine, and innovation in patient care delivery. Prior to joining a16z, Vineeta held many different roles in the healthcare space: as a physician taking care of patients; as an operator at healthtech startups; and as a ve … D and PhD degrees from Harvard Medical School / MIT. She completed her clinical residency at Stanford, and is board certified in internal medicine. Vineeta continues to see patients at Stanford as an adjunct clinical professor in the Division of Primary Care and Population Health. Vineeta serves on several portfolio company boards, including Amber Bio, BigHat Biosciences, Gate Bio, GC Therapeutics, knownwell, Orbital Therapeutics, Pearl Health, Pomelo Care, Rezo Therapeutics, … ia’s largest private bank where she managed a loan portfolio. Pooja is an award-winning thought leader and regular speaker on Bloomberg Asia Day Break and at 100 Women in Finance events. Her numerous coveted awards include Hedge Fund Rising Star 2015, by Institutional Investor; Best Female Hedge Fund Manager, 2016, Eurekahedge; and Tomorrow’s Titan: 2016, by Ernst & Young with Hedge Fund Journal. Pooja is passionate about encouraging and supporting women in as … finalist in the Nucleate Activator Program, receiving the Scientific Excellence Award. Sengstack was a Hillblom graduate fellow and received funding support from Chan Zuckerberg Biohub. She graduated from Cal Poly, San Luis Obispo with her Bachelor of Science in biology, summa cum laude. At Junevity, Sengstack leads development of the RESET disco
Janine Sengstack - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Janine Sengstack Co-Founder and Chief Scientific Officer Janine Sengstack, Ph.D., is a cell biologist and entrepreneur advancing therapeutics for age-related diseases. She co-founded Junevity in 2023 to develop novel siRNA therapeutics for transcription factors, securing over $10 million in venture capital seed funding. During her d … finalist in the Nucleate Activator Program, receiving the Scientific Excellence Award. Sengstack was a Hillblom graduate fellow and received funding support from Chan Zuckerberg Biohub. She graduated from Cal Poly, San Luis Obispo with her Bachelor of Science in biology, summa cum laude. At Junevity, Sengstack leads development of the RESET discovery platform from concept through siRNA candidate nomination for clinical development. Her work to date includes promising programs … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Janine Sengstack | SynBioBeta Speaker Γ SynBioBeta Speaker Janine Sengstack Co-Founder & CSO Junevity SynBioBeta 2025 - Session Speaker How Breakthroughs in Cellular Reprogramming Could Transform Aging Epigenetic reprogramming has rapidly become the hottest area in longevity biotech, attracting unprecedented attention and billions in investment in just the last two years. Building on Shinya Yamanaka's Nobel Prize winning iPSC reprogramming, a new wave of biotech startups are now racing to extend the concept to therapeutically rejuvenate the cells in our bodies. This panel brings together t
Janine Sengstack - Junevity | Obesity Science & Innovation USA (OSI USA) Speaker You need to enable JavaScript to run this app. This site is part of the Informa Connect Division of Informa PLC Informa PLC About Us Investor relations Talent This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. September 23-24, 2026 | Part of Biotech Week Boston Hynes Convention Center Boston, United States Home home 2026 Program expan
PRESS RELEASE — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT PRESS RELEASE Feb 13 Written By Rob Cahill Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity Founded by a team of experts in aging biology, machine learning and drug development and based on pioneering research for resetting cell health by Dr. Janine Sengstack of UCSF Junevity’s RESET platform uses large-scale human data and
Junevity | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Junevity Junevity is a biotechnology company founded at UCSF in 2023, dedicated to extending human healthspan and lifespan through innovative Cell Reset therapeutics. They utilize a platform that combines large-scale human data, AI/ML, and siRNA technology to develop safe and effective therapeutics targeting transcription factors involved in aging and age-related diseases. Their mission is to reverse cellular damage and restore tissue health, aiming to treat diseases
About — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Our vision is to develop siRNA to restore gene networks for major tissues implicated in complex disease. Meet the Leadership Team JOHN HOEKMAN PhD, Co-founder & CEO Founder, CSO, and CEO Impel Pharma. Brought his PhD invention to FDA approval for Trudhesa® for migraines. Inventor on >100 patents. PhD in Pharmaceutics at Univ. of Washington. JANIN … Godfrey Capital (lead), biotech veterans, doctors, tech entrepreneurs and hedge fund managers. Global spend on healthcare due to age-related diseases exceeds $5 trillion annually. We can change this. WELCOME TO A NEW ERA OF DISEASE REVERSAL Contact Us ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT LINKEDIN All Rights Reserved © 2026 Junevity Inc.
Junevity raises funds to advance siRNA metabolism program | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health China's GLP-1 landscape PFA
Junevity and Retro Biosciences advance longevity with AI | Sfoug Alshammary MD,Ph.D. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sig
Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity | Life Sciences VCLink LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Link … age Therapeutics Inc. is making a different bet. With a $2.5M NIH Phase II SBIR grant, the company is advancing AD04—a subcutaneous immunomodulatory candidate that aims to deliver functional slowing without the infusion burden or ARIA monitoring. This isn’t just a scientific play; it’s a deliberate operational and regulatory positioning. AD04 already has UK ILAP designation and European CTAs in place, setting up a confirmatory Phase 2b trial designed for hybrid administration
CONFERENCE — Junevity – Cell Reset for Longevity 0 Skip to Content ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT Open Menu Close Menu ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT CONFERENCE Mar 13 Written By Rob Cahill Dr. Janine Sengstack presents at the 2024 Rejuvenation Startup Summit in Berlin. Read more here . Rob Cahill Previous Previous CONFERENCE ABOUT PLATFORM PIPELINE NEWS CAREERS CONTACT LINKEDIN All Rights Reserved © 2026 Junevity Inc.
Junevity's Bold Move: Using siRNA to Fight Diabetes and Obesity
Junevity Raises $20M to Revolutionize Aging with JUN_01 Therapeutic | Jesse Landry posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign … developing a precision nutrition platform for ALS patients, awarded an Ignition Grant of CHF 30,000. 🔬 GenoRobotics – building a portable DNA sequencing device for fast, accessible species identification, awarded an Innogrant of CHF 100,000. 🧠 Infera Neuro https://infera-neuro.com/ – designing ultra-low-power neural chips to restore communication for patients with ALS, stroke, or spinal cord injuries, awarded an Innogrant of CHF 100,000, sponsored by UBS as part of their co … -in-human clinical trials. With continued participation from the OpenAI Startup Fund, Thrive Capital, and Menlo Ventures, Chai Discovery is now scaling its commercial operations. The goal is to provide pharmaceutical partners with a "CAD suite" for molecules, unleashing a new wave of first-in-class therapeutics that were previously deemed impossible to manufacture. #ChaiDiscovery #BiotechAI #SeriesB #UnicornStartup #DrugDiscovery #GenerativeAI #AntibodyDesign #OpenAI #General